We’re excited to introduce the new Dry Ice Probe, extending the capabilities of TempMonitor BLE (TMBLE) to deliver complete visibility and control in ultra-low temperature applications.  

“Pharmaceutical and clinical supply chains depend on precision at every stage,” says Johanna Eriksson, Chief Product Officer at TSS. “With the new Dry Ice Probes, we’re extending the proven reliability of TempMonitor BLE into ultra-low temperature applications — giving our customers complete visibility and control over product integrity, even in the most demanding conditions.”

Built for Compliance and Scalability

The probe is available in two cable lengths, 100 mm and 300 mm, and deliver accurate and GxP-compliant temperature monitoring from –90°C to –30°C, ideal for pharmaceutical materials stored on dry ice. Designed with a stainless-steel probe and durable Teflon cabling, it ensures reliable performance and long-term stability in demanding ultra-low temperature environments.

Each probe features a PT100 temperature sensor for high-precision readings and is ISO 17025 calibrated to ensure verified performance. The plug-and-play design connects seamlessly to TempMonitor BLE, instantly converting analog readings into validated digital data — streamlining temperature monitoring without the need for additional setup or configuration.

Real-Time Data and Visibility

Through the TSS Gateway, data is securely transmitted to the TSS Cloud, providing real-time visibility and alerts in the TSS Facility and Clinical SaaS Modules. This ensures full data integrity, reduced manual handling, and faster decisions — from storage to shipment.

‍

• Learn more about TempMonitor BLE and the new Dry Ice Probes

‍